While we profiled children as proximal as possible to clinical disease onset, the underlying disease processes may already be well underway prior to clinical manifestations, which may be particularly true in MS where evidence for injury manifesting as elevated serum neurofilament light chain (NfL) levels is documented well prior to clinical disease onset55. The gene discussed is NEFL; the disease is myeloid sarcoma.